BIA-ALCL Evaluation & Surgical Management — Dallas, TX
BIA-ALCL is a rare lymphoma of the immune system — not breast cancer — and Dallas-Fort Worth patients evaluated for it deserve a surgeon whose entire practice is built around implant capsule pathology. Dr. Robert Whitfield is a board-certified plastic surgeon in Austin, TX who performs the oncologic-adequacy en bloc capsulectomy this diagnosis requires.
For the complete diagnostic workup, staging, and treatment detail, review the full BIA-ALCL clinical guide.
Dr. Robert Whitfield, MD • 3 hours by car or 1 hr flight from Dallas • PCR pathology partnership
Why Dallas Patients Choose Dr. Whitfield
Dallas-Fort Worth has board-certified plastic surgeons. What matters for BIA-ALCL specifically is whether that surgeon performs oncologic-adequacy en bloc capsulectomy as standard, has a PCR pathology partnership for every specimen, and can access a second pathology opinion at a tertiary cancer center for equivocal findings. This is surgical management, coordinated with medical oncology when disease extends beyond the capsule — not an in-house cancer treatment center.
Dr. Whitfield’s practice in Austin is 3 hours by car or 1 hr flight from Dallas. Most patients complete their consultation remotely, then travel to Austin for surgery.
Surgical & Pathology Differentiators
What to Expect as a Dallas Patient
Discovery Call (remote)
A structured call with Dr. Whitfield’s team to review imaging, symptoms, and any prior pathology findings. No travel required.
Surgical consultation (remote or in-person)
Surgical planning can be completed by video. Imaging and prior records can be submitted from Dallas in advance.
Surgery in Austin
Travel to Austin for oncologic-adequacy en bloc capsulectomy at a certified surgical facility.
Recovery and coordinated follow-up
A brief post-operative period in Austin is recommended before returning to Dallas. If pathology shows disease beyond the capsule, follow-up is coordinated with medical oncology/hematology.
Frequently Asked Questions
Why should I travel to Austin for BIA-ALCL surgical management instead of a Dallas surgeon?
The relevant clinical question is whether your Dallas surgeon performs the oncologic-adequacy en bloc technique this diagnosis requires, has a PCR pathology partnership for every specimen, and can route equivocal findings to a second pathology consultation at a tertiary cancer center. Dr. Whitfield's Austin practice offers all three. It is not an in-house cancer center — surgical management is provided here, and any needed systemic therapy is coordinated with medical oncology and hematology.
What should I do if I have a late seroma or mass and I'm worried about BIA-ALCL?
See a physician promptly for imaging and fluid evaluation — this is not something to watch and wait on, but it is also not a reason to panic. BIA-ALCL is a rare lymphoma, not breast cancer, and most cases identified early are curable with surgery alone.
What if a prior capsulectomy in Dallas didn't fully address a suspicious finding?
Incomplete prior capsule removal is one of the first things evaluated when a Dallas patient is referred with a persistent finding. Retained capsule tissue can complicate both diagnosis and treatment, which is why complete, oncologic-adequacy resection matters from the first surgery.
How is an Austin stay planned after surgery?
The Austin stay is planned around the surgical findings and any coordinated oncology follow-up. Dr. Whitfield's team provides individualized travel and follow-up guidance during surgical planning.
You Deserve a Surgeon Who Prepares You, Not Just Operates on You.
Dr. Robert Whitfield has guided thousands of patients through surgical decisions with clarity, data, and a personalized plan. Your consultation is where that plan begins.
Not ready to book? Download the free Inflammation Support Guide to start your journey.